CSRxP Statement on President Trump’s Meeting With Big Pharma Executives

05-8-2017 Press Release

“Transparency is one of the keys to market-based reforms that will lead to lower prices and ensure that taxpayers receive a real return on their investment.”

CSRxP Launches National Campaign to Hold Big Pharma Accountable

05-2-2017 Press Release

CSRxP has launched a national campaign as part of a multi-million-dollar effort to hold Big Pharma accountable for their out-of-control prescription drug prices. Because Big Pharma blocks competition to maintain monopolies on medicines, they can set any price they want.

CSRxP Applauds Introduction of the CREATES Act

04-27-2017 Blog PostsPress Release

“Big Pharma’s longstanding pattern of utilizing the REMS process to forestall generic and biosimilar medications from reaching patients is an anticompetitive and cynical abuse of an important tool for patient safety.”

CSRxP Applauds Introduction of FAST Generics Act

04-7-2017 Press Release

“The FAST Generics Act represents market-based reforms that will increase competition and ensure that lifesaving medications can safely reach patients at an affordable price.”

American Academy of Family Physicians Joins CSRxP

04-6-2017 Press Release

American Academy of Family Physicians Joins CSRxP The Campaign for Sustainable Rx Pricing (CSRxP) today announced that the American Academy of Family Physicians (AAFP) joined the Campaign.  Founded 70 years ago, the AAFP represents 124,900 physicians and medical students nationwide, and is the only medical society devoted solely to primary care. AAFP joins a broad-based campaign that includes […]

CSRxP Calls For Further Action on Rx Prices

03-3-2017 Press Release

“We must ‘bring down the artificially high price of drugs and bring them down immediately.’ That’s what the President said in his address to Congress – and the American people agree.

CSRxP Applauds Trump Administration’s Focus on Lowering Prescription Drug Prices

01-31-2017 Press Release

We applaud President Trump for making the out-of-control prices of prescription drugs a priority in his Administration.

CSRxP on PhRMA’s Multimillion-Dollar PR Campaign

01-23-2017 Press Release

“No amount of advertising will make hardworking families forget the consequences of their out-of-control drug costs.”

High-Priced Drugs Driving Increased Taxpayer Spending, HHS Report Shows

01-5-2017 Press Release

A new HHS Office of the Inspector General report finds that high-priced prescription drugs are threatening the sustainability of the taxpayer-funded Medicare Part D program.

CSRxP Blasts Novo Nordisk’s Plans for Prescription Price Hikes

12-7-2016 Press Release

Based on Novo Nordisk’s announcement, it is clear that the company will continue to hike insulin prices, despite the financial burdens already facing patients. “The prescription drug market is clearly broken when limiting yearly price increases to ten percent is considered bighearted,” said John Rother.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.